In February, a group of pro-abortion doctors penned a commentary for the New England Journal of Medicine explaining why the drug Mifepristone should be available in pharmacies, citing safety and convenience. This group was spearheaded by Dr. Daniel Grossman of the ANSIRH program (Advancing New Standards in Reproductive Health) at the University of California, San Francisco, the same program that produced this fatally-flawed study (which I wrote about here).
For the unfamiliar, Mifepristone is a progesterone blocker. A woman in the early stages of pregnancy can take the Mifepristone pill, and it will cause the lining of her uterus to detach. This in turn will deprive the child of nutrients, bringing about the child’s death. Between 24 to 48 hours later, the woman will take another pill, Misoprostol, which will cause contractions and allow her to deliver the dead child.
Continue reading this article by clicking here